Novo Nordisk is currently locked in a bidding war with Pfizer for U.S. biotech firm Metsera.
Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount
Related Posts
China’s industrial profits extend decline to a fourth straight month, dropping 7.3% in November
China’s industrial profits extended their decline to a fourth straight month, dropping 7.3% in November from a year earlier.
Asia markets trade mixed after Wall Street gains as investors look past government shutdown
Investors in Asia are also looking to Japan’s September manufacturing purchasing managers’ index later in the day.
Gemini Robotics 1.5: DeepMind’s ER↔VLA Stack Brings Agentic Robots to the Real World
Can a single AI stack plan like a researcher, reason over scenes, and transfer motions across different robots—without retraining from…